PRAPA, MALVINA
 Distribuzione geografica
Continente #
NA - Nord America 2.007
AS - Asia 1.333
EU - Europa 1.307
SA - Sud America 173
AF - Africa 27
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.858
Nazione #
US - Stati Uniti d'America 1.956
IT - Italia 505
SG - Singapore 460
CN - Cina 329
GB - Regno Unito 211
VN - Vietnam 159
HK - Hong Kong 146
BR - Brasile 122
DE - Germania 107
SE - Svezia 89
RU - Federazione Russa 67
FR - Francia 64
FI - Finlandia 49
KR - Corea 43
IE - Irlanda 38
UA - Ucraina 35
TR - Turchia 33
AL - Albania 29
JP - Giappone 27
ID - Indonesia 25
IN - India 23
MX - Messico 23
BE - Belgio 20
CA - Canada 20
AR - Argentina 17
NL - Olanda 17
BD - Bangladesh 16
ES - Italia 13
BG - Bulgaria 12
EC - Ecuador 11
PK - Pakistan 11
PL - Polonia 10
AU - Australia 9
AT - Austria 8
ZA - Sudafrica 8
CZ - Repubblica Ceca 7
IQ - Iraq 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
MA - Marocco 5
MY - Malesia 5
PE - Perù 5
PT - Portogallo 5
AZ - Azerbaigian 4
EG - Egitto 4
IL - Israele 4
JO - Giordania 4
NP - Nepal 4
SI - Slovenia 4
UZ - Uzbekistan 4
VE - Venezuela 4
CO - Colombia 3
LK - Sri Lanka 3
LT - Lituania 3
RO - Romania 3
UY - Uruguay 3
BB - Barbados 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DZ - Algeria 2
EU - Europa 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
MD - Moldavia 2
MK - Macedonia 2
MN - Mongolia 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
TN - Tunisia 2
TW - Taiwan 2
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
LB - Libano 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
RS - Serbia 1
SY - Repubblica araba siriana 1
Totale 4.858
Città #
Singapore 320
Ashburn 238
Santa Clara 218
Fairfield 153
Hong Kong 140
Hefei 115
Chandler 114
San Jose 107
Southend 100
Woodbridge 82
Ann Arbor 81
Houston 76
Seattle 66
Ho Chi Minh City 58
Wilmington 56
Cambridge 53
Bologna 50
Beijing 49
London 47
Modena 47
Nyköping 47
Milan 44
Dearborn 43
Hanoi 41
Los Angeles 40
New York 40
Seoul 39
Helsinki 38
Dublin 37
Munich 35
The Dalles 32
Council Bluffs 28
Jacksonville 26
Tirana 22
Jakarta 20
Lauterbourg 20
San Diego 20
Brussels 19
Chicago 17
São Paulo 17
Florence 16
Moscow 15
Parma 15
Rome 15
Frankfurt am Main 13
Izmir 12
Reggio Emilia 12
Tokyo 12
Buffalo 11
Dallas 11
Fremont 11
Orem 11
Boardman 10
Falls Church 10
Mexico City 10
Nuremberg 10
Princeton 10
Sofia 10
Redondo Beach 9
San Giuliano Milanese 9
Warsaw 9
Adelaide 8
Phoenix 8
Bremen 7
Da Nang 7
Denver 7
Eugene 7
Genoa 7
Manchester 7
Montreal 7
Shinjuku 7
Brno 6
Guangzhou 6
Haiphong 6
Romola 6
Vienna 6
Amsterdam 5
Aydin 5
Brooklyn 5
Chennai 5
Chieti 5
Columbus 5
Fisciano 5
Grimes 5
Hillsboro 5
Kent 5
Kyiv 5
Monselice 5
Padova 5
Quito 5
Ravenna 5
Salt Lake City 5
Salvador 5
Shanghai 5
Taranto 5
Turin 5
Turku 5
Baku 4
Dong Ket 4
Guayaquil 4
Totale 3.255
Nome #
GD2 expression in breast cancer. 419
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 410
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 380
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 373
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 360
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 318
Detection of microparticles from human red blood cells by multiparametric flow cytometry 303
GD2 CAR T cells against human glioblastoma 291
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 291
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma 240
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 236
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells 234
Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA 194
Developing cell therapies as drug products 194
Adoptive CAR T Cell Therapy Targeting GD2-Positive Cancers 179
CAR-modified killer MSC targeting GD2-positive Ewing sarcoma 165
Anti-GD2 chimeric antigen receptor & trail modified mesenchymal progenitors as novel strategy against ewing’s sarcoma 146
5P Anti-GD2 chimeric antigen receptor & TRAIL modified mesenchymal progenitors as novel strategy against Ewing’s sarcoma 120
Terapia adottiva con linfociti T modificati con un recettore antigenico chimerico (CAR) per la cura di neoplasie GD2-positive 74
Totale 4.927
Categoria #
all - tutte 15.989
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.989


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 0 17 31
2021/2022405 3 40 15 14 19 40 44 36 41 34 74 45
2022/2023408 47 44 29 39 52 35 12 47 67 8 20 8
2023/2024259 16 15 27 23 34 21 18 32 12 7 12 42
2024/20251.196 26 34 75 98 170 194 138 59 142 49 79 132
2025/20261.774 163 73 160 225 309 109 253 83 165 204 30 0
Totale 4.927